A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel
Keywords:
basal cell carcinoma, vismodegib, chemotherapy, carboplatin, metastaticReferences
Cappilli S, Dejonckheere G, Hajjar N, et al. Line-field confocal optical coherence tomography: a case on the importance of full-lesion examination for basal cell carcinoma. Int J Dermatol. 2022;61(7):e248-e250. DOI: 10.1111/ijd.15930. PMID: 34591332.
Cappilli S, Cinotti E, Lenoir C, et al. Line-field confocal optical coherence tomography of basosquamous carcinoma: a case series with histopathological correlation. J Eur Acad Dermatol Venereol. 2022;36(8):1214-1218.. DOI: 10.1111/jdv.18038. PMID: 35224784.
Iarrobino A, Messina JL, Kudchadkar R, Sondak VK. Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib. J Am Acad Dermatol. 2013;69(1):e33-e34. DOI: 10.1016/j.jaad.2013.01.023. PMID: 23768306.
Bancalari B, Llombart B, Serra-Guillén C, et al. Histologic Changes During Treatment With Vismodegib in Locally Advanced Basal Cell Carcinoma: A Series of 19 Cases. Am J Dermatopathol. 2019;41(10):711-717. DOI: 10.1097/DAD.0000000000001384. PMID: 31436575.
Apalla Z, Giakouvis V, Gavros Z, et al. Complete response of locally advanced basosquamous carcinoma to vismodegib in two patients. Eur J Dermatol. 2019;29(1):102-104. DOI: 10.1684/ejd.2018.3482. PMID: 30998204.
Jefford M, Kiffer JD, Somers G, Daniel FJ, Davis ID. Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ J Surg. 2004;74(8):704-705. DOI: 10.1111/j.1445-1433.2004.03130.x. PMID: 15315581.
Published
Issue
Section
License
Copyright (c) 2022 Chryssoula Papageorgiou, Zoe Apalla, Eleni Timotheadou, Konstantia Loga, Elizabeth Lazaridou, Dimitrios Dionysopoulos

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

